CD274 and neoplasm: miR-152 directly targets the 3′ UTR of B7-H1 mRNA in gastric cancer cells to inhibit its expression, which promotes T cell function and enhances the anti-tumor immune response by blocking the B7-H1/PD-1 signaling pathway, ultimately reducing immune escape (Figure 6B).